FDA issues show cause notices to 17 Pharma manufacturers: Maharashtra

“In Maharashtra, there are total 996 allopathic manufacturers, of which 514 manufacturers export their products."

1376
Food and Drugs Administration FDA Maharashtra
FDA Maharashtra

Last Updated on January 20, 2024 by The Health Master

The Food and Drug Administration (FDA) Maharashtra department minister Sanjay Rathod informed the Maharashtra legislative assembly that a total of 84 cough syrup manufacturing companies have been inspected in the state out of which 17 have been show caused.

In the same list, four companies have been have been instructed to stop their productions and licenses of six companies have been terminated.

Rathod gave the information in state assembly on Friday while he was responding to calling attention motion given by MLA Ashish Shelar.

“It was mandatory to export medicines manufactured within the state after conducting the stability test.”

“But it has been found that in February 2023, as many as 2,000 medicines manufactured by over 200 drug manufacturers in the state were being exported without any kind of stability test certificate,” he added.

“An inquiry must be set up on these drug manufacturing companies and also the licences of those found guilty should be terminated.”

Shelar also demanded a case of culpable homicide must be registered against these companies.

Responding to the motion in house, Rathod said that the FDA department issued a circular on October 7, 2022 where it was stated inspections will be carried out against manufacturers of oral syrups in the state.

“In Maharashtra, there are total 996 allopathic manufacturers, of which 514 manufacturers export their products.”

“Last year, nearly 8,259 retailers were inspected and show cause notices were sent to 2,000 retailers.”

“Licences of 424 were cancelled and offences were registered against 56 retailers. This is a serious matter and our department is doing a commendable job.”

“The department will also take cognizance of new complaints” Rathod added.

Pharma API Leaders discusses regulatory compliance

USFDA gives approval for Rocuronium Bromide Injection

22 Pharma Firms come under GST radar

Spurious drugs worth Rs 7.3 cr seized in UP: Odisha connection

Govt soon to announce R&D policy for Pharma Sector

Spurious drugs worth Rs 2 lakh seized, distributor arrested

NPPA revised Ceiling price of 80 scheduled formulations: February 2023

India aims to be the world’s most respected drugs regulator: HM

Duties and responsibilities of QA person in Pharma Industry

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news